Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ:MRVI)

U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) rose sharply during Tuesday’s session.

BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday

April 09, 2024

Via Benzinga

Topics Stocks

Recap: Maravai LifeSciences Q4 Earnings

February 22, 2024

Via Benzinga

Dyadic International Inc. (NASDAQ: DYAI) Funding to Propel Near-Term Revenue Growth Initiatives Highlights in Zacks Small-Cap Research Report

April 04, 2024

Topics Regulatory Compliance

Maravai LifeSciences Announces March 2024 Investor Conference Schedule

March 12, 2024

Market Momentum: NASDAQ SmallCaps Sparking Waves in March 2024: CELZ, DYAI, GROM, VTAK, BREA

March 08, 2024

Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS

February 28, 2024

Healthcare Undervalued Opportunities Poised for Growth: DYAI, INBS, VTAK, RSCI, VERO, MRVI

February 26, 2024

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling around 0.2% on Friday. The Dow traded up 0.23% to 39,158.52 while the NASDAQ fell 0.19% to 16,011.27. The S&P 500...

Nasdaq Edges Lower; AXT Shares Surge After Q4 Results

February 23, 2024

Via Benzinga

Topics Stocks

Small-Cap Maravai LifeSciences' Q4 Outperforms Expectations, Analyst shows Optimism Around 2024 Guidance

February 23, 2024

Maravai LifeSciences impresses with Q4 2023 revenue of $74.1 million, surpassing estimates. CEO Trey Martin highlights strong execution, cost reductions, and a 28% adjusted EBITDA margin. 2024 revenue...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session

February 23, 2024

Via Benzinga

Crude Oil Down 2%; Maravai LifeSciences Shares Spike Higher

February 23, 2024

U.S. stocks traded mostly higher midway through trading, with the Dow Jones index jumping more than 100 points on Friday. The Dow traded up 0.36% to 39,209.32 while the NASDAQ rose 0.01% to 16,042.80....

Via Benzinga

Topics Stocks

Why MercadoLibre Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

February 23, 2024

Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company reported fourth-quarter financial results.

Via Benzinga

Carvana Posts Q4 Results, Joins LegalZoom.com, Comfort Systems And Other Big Stocks Moving Higher On Friday

February 23, 2024

U.S. stocks were mostly higher, with the Dow Jones index gaining more than 100 points on Friday.

Via Benzinga

Topics Stocks

Dow Surges Over 150 Points; AerCap Posts Upbeat Earnings

February 23, 2024

U.S. stocks traded higher this morning, with the Dow Jones index jumping more than 150 points on Friday.

Via Benzinga

Topics Stocks

Why AXT Shares Are Trading Higher By Around 36%; Here Are 20 Stocks Moving Premarket

February 23, 2024

Shares of AXT, Inc. (NASDAQ: AXTI) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session

February 23, 2024

Via Benzinga

Nasdaq, S&P 500 Set for Mixed Open After Nvidia Euphoria: Analyst Picks Major Market Catalyst This Year If There Are No Rate Cuts

February 23, 2024

After the exuberance seen on Thursday, investors may assess whether it was an irrational one, and futures trading on Friday reflects edginess.

Via Benzinga

Topics Stocks

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

February 23, 2024

It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!

Via InvestorPlace

Maravai LifeSciences (MRVI) Q4 2023 Earnings Call Transcript

February 22, 2024

MRVI earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

12 Health Care Stocks Moving In Thursday's After-Market Session

February 22, 2024

Via Benzinga

Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results

February 22, 2024

Continued Focus on Expanding Product Portfolio, Market Leadership and Innovation

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million.

Earnings Scheduled For February 22, 2024

February 22, 2024

Via Benzinga

TriLink BioTechnologies® Solidifies IP Position with Awarded Patents for CleanCap® Capping Technology in China and Canada

February 21, 2024

From TriLink BioTechnologies

Via Business Wire

Nasdaq Stocks Are Taking Center Stage This Week! DYAI, MRVI, SPWR, VTAK, KAVL, INBS

February 19, 2024

Biopharmaceutical Advancements: Dyadic (Nasdaq: DYAI) Raises Industry Standards with Maravai LifeSciences’ (Nasdaq: MRVI) Cygnus Technologies

February 14, 2024

Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing

February 13, 2024

From Dyadic International, Inc.

Spot the looming risks in the biotech sector and avoid these three doomed biotech stocks likely to burn shareholder value significantly.

3 Doomed Biotech Stocks to Dump Before They Dive: February 2024

February 11, 2024

Via InvestorPlace

Maravai LifeSciences To Host Earnings Conference Call on Thursday, February 22, 2024

January 29, 2024